You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
LASH- Binocular Multispectral Adaptive Imaging System (BMAIS)
SBC: Sage Technologies, Ltd. Topic: AF083015Low Altitude Sensing Helmet -(LASH) is to provide for pilot night vision when using small non-military planes to operate using unimproved landing areas around the globe. LASH will use SWIR (Short Wave IR) and LWIR (Long Wave IR) technology sensors to provide improved night vision in specified conditions.
SBIR Phase II 2019 Department of DefenseAir Force -
Wing and Bomb Bay Launched (WBBL) Unmanned Air Vehicle (UAV)
SBC: PIASECKI AIRCRAFT CORP Topic: N05005Ibis’ baseline design balances the competing demands of low cost and high performance. The proposed baseline allows for the incorporation of high-rate production technologies which also provide the most functional shapes, minimizing cost and maximizing performance. Ibis’ layout features a streamlined fuselage, high aspect ratio swept wings and non-foldable tail-planes which sum up to ...
SBIR Phase II 2019 Department of DefenseAir Force -
Ultimate Passive Dosimeter
SBC: MYEXPOSOME INC Topic: DHP15009Thelack of low cost,maintenance-free,easy-to-wear personal samplingtechnology hinders assessment ofchemicalexposuresespecially in deployed military populations.We are developing a silicone wristband for use as a passivemonitor forenvironmentalexposure. Silicone wristband personal dosimeters (PDs) are uniquein being ableto measure both volatile(VOCs) and semi-volatile(SVOCs)compounds,capturing bioa ...
SBIR Phase II 2019 Department of DefenseDefense Health Agency -
Biphase Extended Release Tablet Formulation for Nerve Agent Pretreatment
SBC: ZYMERON CORP Topic: CBD181004Nerve agents exert their toxic effect by binding to and inactivating enzyme acetylcholinesterase, a key enzymatic regulator of cholinergic neurotransmission. The binding becomes irreversible after a varying amount of time with nerve agents and this aging process limits the treatment window of oxime reactivators. To enhance the current antidote treatment of nerve agent autoinjectors, a pyridostigmi ...
SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense -
Natural Rubber Production
SBC: EDISON AGROSCIENCES INC Topic: ST18C001Natural rubber is an essential manufacturing material that possesses performance properties that are superior to synthetic rubber for many product applications. However, natural rubber production is limited to a single species (rubber tree) in a limited geographic area (Southeast Asia) and is predicted to be incapable of meeting future demand. Producing rubber from another commercial crop such as ...
STTR Phase I 2019 Department of DefenseDefense Advanced Research Projects Agency -
Solar Blind Deep UV Avalanche Photo Detectors and Arrays
SBC: ADROIT MATERIALS, INC. Topic: ST18C003The objective of this project is to develop a compact and efficient avalanche photodiode (APD), operating between 200-250 nm, for implementation in the next generation bio-chem-detectors. The proposed detectors will be based on the AlGaN materials system and will be solar blind, highly sensitive, smaller, less expensive, and more robust than current UV detectors. Development of such APDs will enab ...
STTR Phase I 2019 Department of DefenseDefense Advanced Research Projects Agency -
Genetically Engineered Pancreatic Organoids Composed of Extracellular Matrix Hydrogels for the Purpose of Long-Term Therapeutic Glycemic Maintenance
SBC: ECMedical LLC Topic: ST18C004Glucose abnormalities significantly affect patient morbidity and mortality. Currently, glycemic control is achieved via medications and exogenous insulin regimens that are costly both in terms of qualified personnel and consumables. Furthermore, none of these approaches are curative. Strategies under development such artificial pancreases do not necessarily address these limitations because they w ...
STTR Phase I 2019 Department of DefenseDefense Advanced Research Projects Agency -
Cost Effective, Freestanding Super-Resolving Phase Filter for UV, VIS, and IR Wavelengths
SBC: NuSpot Technologies, LLC Topic: SB172004In this effort, NuSpot Technologies, LLC proposes the development of a cost-effective, self-contained and easy to manufacture Superresolving Phase Filter capable of generating a sub-wavelength scale, or “superresolved,” spot of electromagnetic radiation that can be customized to operate at a given target wavelength in the IR, Vis, or UV. Successful completion of this SBIR project will enable: ...
SBIR Phase II 2019 Department of DefenseDefense Advanced Research Projects Agency -
CrasHD: Semantics-Aware, Human-Assisted, Security-Critical Data Triage in COTS Application Crashes
SBC: ZeroPoint Dynamics LLC Topic: SB173003Over a decade ago, security practitioners highlighted threats posed by memory corruption exploits subverting systems through manipulation of security-critical non-control-data — without ever corrupting application control-flow. Since that demonstration, however, the full power of data-oriented attacks went largely unnoticed until very recently. One reason for this recent emergence is that exploi ...
SBIR Phase II 2019 Department of DefenseDefense Advanced Research Projects Agency -
Wearable Ultrasound for Imaging and Modulation
SBC: THE ULTRAN GROUP, INC. Topic: SB173001The Ultran Group, Inc., will further develop its wearable ultrasound technology and commercialize a Class II medical device for treatment of inflammation caused by rheumatoid arthritis. The developed technology will be a platform for additional therapies including pain treatment, immunotherapy, and cancer treatment. For this SBIR Phase II effort, Ultran will continue to work closely with the Unive ...
SBIR Phase II 2019 Department of DefenseDefense Advanced Research Projects Agency